Patent Filing
Treatment of Inflammatory Disorders by Neurostimulation
Setpoint Medical Corporation3/24/2026·03/24/26🌐 USA
Summary
Methods and apparatuses for treating inflammatory diseases by neurostimulation in patients who have failed to adequately respond or have become intolerant to drug therapies such as TNF inhibitors and/or JAK inhibitors. Uses an implanted leadless device comprising a pulse generator and at least one electrode.
Why it matters
Expands neurostimulation beyond pain management into autoimmune/inflammatory disease treatment, opening a massive new market including rheumatoid arthritis and Crohn's disease.
#Neurostimulation#Bioelectronic Medicine#Chronic Pain#FDA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in